Annika Schmid

Annika Schmid currently serves as Director of R&D Program Management at BioNTech SE since July 2023, following a long tenure at MorphoSys from August 2009 to July 2023, where roles included Director and Associate Director in Antibody Discovery for Proprietary Programs. Annika led cross-functional teams to transition projects from pre-clinical to clinical development, overseeing various aspects such as hiring, resource planning, and project management. Prior experience includes positions ranging from Senior Scientist to Scientist in Customer Projects, focusing on monoclonal antibody identification and characterization. Annika's academic background includes a postdoctoral position in Medical Microbiology at Ludwig-Maximilians-Universität München, complemented by a Diplom in Biology from the same institution.